Tyrosinemia

• CLINICAL_TRIALS trial_result · 2026-02-19
  Clinical Trial Update: Evaluation of the Express Plus Range [NA]

  A completed clinical trial evaluated Vitaflo's Express Plus Range for multiple metabolic disorders including phenylketonuria, homocystinuria…

• CLINICAL_TRIALS research · 2025-12-19
  Clinical Trial Update: GMP Powdered Substitutes in PKU and TYR [NA]

  A Nutricia UK Ltd-sponsored clinical trial evaluating GMP powdered substitutes for phenylketonuria and tyrosinemia is currently recruiting.

• CLINICAL_TRIALS trial_result · 2025-11-28
  Clinical Trial Update: Evaluation of TYR Sphere in France [NA]

  A completed clinical trial in France evaluated TYR Sphere for tyrosinemia and alkaptonuria.

• EMA withdrawal · 2023-06-14
  EMA Withdrawn: Nitisinone MDK (previously Nitisinone MendeliKABS) (nitisinone) — MendeliKABS Europe Ltd

  EMA withdrawal of nitisinone MDK (nitisinone) from MendeliKABS Europe Ltd for tyrosinemias.

• EMA approval · 2023-06-05
  EMA Authorised: Nityr (nitisinone) — Cycle Pharmaceuticals (Europe) Ltd

  Nityr (nitisinone) has been authorised in Europe for treatment of tyrosinemias.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.